- Home
- CPRX vs INDB Comparison
CPRX vs INDB Comparison
Compare CPRX & INDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CPRX | INDB |
|---|---|---|
| Founded | 2002 | 1907 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.8B |
| IPO Year | 2006 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CPRX | INDB |
|---|---|---|
| Price | $31.17 | $78.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 4 |
| Target Price | $35.00 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 2.3M | 318.0K |
| Earning Date | 05-11-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 3.32% |
| EPS Growth | ★ 28.24 | N/A |
| EPS | ★ 1.68 | 1.63 |
| Revenue | ★ $119,072,803.00 | N/A |
| Revenue This Year | $9.20 | $33.83 |
| Revenue Next Year | $10.51 | $5.85 |
| P/E Ratio | ★ $18.54 | $48.00 |
| Revenue Growth | ★ 16.39 | N/A |
| 52 Week Low | $19.05 | $59.61 |
| 52 Week High | $32.56 | $87.00 |
Technical Indicators
Market Signals| Indicator | CPRX | INDB |
|---|---|---|
| Relative Strength Index (RSI) | 73.25 | 52.90 |
| Support Level | $22.41 | $76.77 |
| Resistance Level | $32.56 | $81.80 |
| Average True Range (ATR) | 1.30 | 1.54 |
| MACD | 0.30 | -0.01 |
| Stochastic Oscillator | 80.10 | 64.76 |
Price Performance
Historical ComparisonAbout CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.
About INDB Independent Bank Corp.
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.